{"id":"https://openalex.org/W4309226285","doi":"https://doi.org/10.1109/niles56402.2022.9942398","title":"Supervised ML for Identifiying Biomarkers Driving the Response to ICBs in Melanoma patients","display_name":"Supervised ML for Identifiying Biomarkers Driving the Response to ICBs in Melanoma patients","publication_year":2022,"publication_date":"2022-10-22","ids":{"openalex":"https://openalex.org/W4309226285","doi":"https://doi.org/10.1109/niles56402.2022.9942398"},"language":"en","primary_location":{"id":"doi:10.1109/niles56402.2022.9942398","is_oa":false,"landing_page_url":"https://doi.org/10.1109/niles56402.2022.9942398","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2022 4th Novel Intelligent and Leading Emerging Sciences Conference (NILES)","raw_type":"proceedings-article"},"type":"conference-paper","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038894154","display_name":"Hajar Elshora","orcid":"https://orcid.org/0000-0001-9581-256X"},"institutions":[{"id":"https://openalex.org/I57629906","display_name":"Nile University","ror":"https://ror.org/03cg7cp61","country_code":"EG","type":"education","lineage":["https://openalex.org/I57629906"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hagar Elshora","raw_affiliation_strings":["Center of Informatics Science Nile University,Giza,Egypt","Center of Informatics Science Nile University, Giza, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Informatics Science Nile University,Giza,Egypt","institution_ids":["https://openalex.org/I57629906"]},{"raw_affiliation_string":"Center of Informatics Science Nile University, Giza, Egypt","institution_ids":["https://openalex.org/I57629906"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069484090","display_name":"Mohamed El-Hadidi","orcid":"https://orcid.org/0000-0002-0360-3654"},"institutions":[{"id":"https://openalex.org/I57629906","display_name":"Nile University","ror":"https://ror.org/03cg7cp61","country_code":"EG","type":"education","lineage":["https://openalex.org/I57629906"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohamed El-Hadidi","raw_affiliation_strings":["Center of Informatics Science Nile University,Giza,Egypt","Center of Informatics Science Nile University, Giza, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Informatics Science Nile University,Giza,Egypt","institution_ids":["https://openalex.org/I57629906"]},{"raw_affiliation_string":"Center of Informatics Science Nile University, Giza, Egypt","institution_ids":["https://openalex.org/I57629906"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I57629906"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22200647,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"15","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9987999796867371,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9987999796867371,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9706000089645386,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-system","display_name":"Immune system","score":0.8112694025039673},{"id":"https://openalex.org/keywords/immune-checkpoint","display_name":"Immune checkpoint","score":0.7154486179351807},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"Immunotherapy","score":0.7055229544639587},{"id":"https://openalex.org/keywords/melanoma","display_name":"Melanoma","score":0.5315767526626587},{"id":"https://openalex.org/keywords/cytotoxic-t-cell","display_name":"Cytotoxic T cell","score":0.5306759476661682},{"id":"https://openalex.org/keywords/immunology","display_name":"Immunology","score":0.49003636837005615},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.45782217383384705},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.43057942390441895},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"Cancer immunotherapy","score":0.4255756139755249},{"id":"https://openalex.org/keywords/cancer-research","display_name":"Cancer research","score":0.4254203736782074},{"id":"https://openalex.org/keywords/blockade","display_name":"Blockade","score":0.4144701659679413},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.2771878242492676},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.11841151118278503}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.8112694025039673},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.7154486179351807},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7055229544639587},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5315767526626587},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5306759476661682},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.49003636837005615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45782217383384705},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43057942390441895},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4255756139755249},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4254203736782074},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4144701659679413},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2771878242492676},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11841151118278503},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1109/niles56402.2022.9942398","is_oa":false,"landing_page_url":"https://doi.org/10.1109/niles56402.2022.9942398","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2022 4th Novel Intelligent and Leading Emerging Sciences Conference (NILES)","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1969761972","https://openalex.org/W2118258530","https://openalex.org/W2130410032","https://openalex.org/W2145341676","https://openalex.org/W2179438025","https://openalex.org/W2323326409","https://openalex.org/W2432815617","https://openalex.org/W2559588208","https://openalex.org/W2747107882","https://openalex.org/W2761575992","https://openalex.org/W2797309423","https://openalex.org/W2887187316","https://openalex.org/W2897815318","https://openalex.org/W2914335731","https://openalex.org/W2978943095","https://openalex.org/W2990435446","https://openalex.org/W3042896257","https://openalex.org/W3043703771","https://openalex.org/W3095300548","https://openalex.org/W3095666019","https://openalex.org/W3126577181","https://openalex.org/W3135028703","https://openalex.org/W3162538759","https://openalex.org/W3163284774","https://openalex.org/W4205247356","https://openalex.org/W6700755198","https://openalex.org/W6718263351","https://openalex.org/W6730203642","https://openalex.org/W6745410717","https://openalex.org/W6780678876"],"related_works":["https://openalex.org/W4393219064","https://openalex.org/W2263980547","https://openalex.org/W2085972006","https://openalex.org/W4361271945","https://openalex.org/W3197188017","https://openalex.org/W4200507838","https://openalex.org/W4362515066","https://openalex.org/W4362158722","https://openalex.org/W3166800855","https://openalex.org/W2575161424"],"abstract_inverted_index":{"The":[0],"Immune":[1,126],"Checkpoint":[2,127],"Blockade":[3],"has":[4],"transformed":[5],"cancer":[6,57],"treatment.":[7],"Cytotoxic":[8],"T-Lymphocyte":[9],"Associated":[10],"Protein":[11],"4":[12],"(CTLA4),":[13],"Programmed":[14],"death-1":[15],"(PD-1)":[16],"are":[17,72,78,101,119],"antibodies":[18],"that":[19,24,77,118,227],"block":[20],"immune":[21,49,75,86,147,152,187,220,249],"checkpoint":[22,153],"proteins":[23],"have":[25],"been":[26],"FDA":[27],"approved":[28],"for":[29,215,219],"treating":[30],"a":[31,109,197,233],"variety":[32],"of":[33,51,99,112,115,140,145,174,185,211,225],"cancers":[34],"including":[35],"melanoma,":[36],"renal":[37],"carcinoma,":[38],"and":[39,55,69,136,166,189,251],"non-small":[40],"cell":[41,148],"lung":[42],"cancer.":[43],"Immunotherapy":[44,180],"tend":[45],"to":[46,53,83,88,105,125,133,162,202],"stimulate":[47],"the":[48,85,91,116,138,143,164,175,183,186,223,235,244,248],"system":[50,188,250],"patients":[52,100],"detect":[54],"kill":[56],"cells":[58,62,76,236],"while":[59],"sparing":[60],"normal":[61],"by":[63],"using":[64],"checkpoints":[65],"such":[66,123],"as":[67,207,209,241,243],"CTLA-4":[68],"PD-1,":[70],"which":[71,107],"molecules":[73],"on":[74,80],"turned":[79],"or":[81,103,121,156],"off":[82],"allow":[84],"response":[87,93,124,155,171],"begin.":[89],"Despite":[90,142],"high":[92],"rate":[94],"in":[95,179],"Melanoma":[96],"patients,":[97],"majority":[98],"resistant":[102],"refractory":[104],"treatment,":[106],"is":[108,129,160,182],"major":[110],"cause":[111],"death.":[113],"Identification":[114],"components":[117],"driving":[120,169,230],"prohibiting":[122],"Therapy":[128],"an":[130],"emerging":[131],"need":[132],"thoroughly":[134],"understand":[135],"regulate":[137],"use":[139],"Immunotherapy.":[141],"identification":[144,224],"several":[146],"subsets":[149],"linked":[150],"with":[151],"inhibitor":[154],"resistance,":[157],"further":[158],"research":[159,181],"needed":[161],"assess":[163],"drivers":[165],"underlying":[167],"mechanisms":[168],"therapy":[170],"response.":[172,221,231],"One":[173],"most":[176],"difficult":[177],"challenges":[178],"complexity":[184],"transferring":[190],"this":[191,199],"information":[192],"into":[193],"clinical":[194],"practice.":[195],"As":[196,232],"result,":[198,234],"study":[200],"aims":[201],"investigate":[203],"traditional":[204],"profiling":[205],"data":[206],"well":[208,242],"application":[210],"Machine":[212],"Learning":[213],"Algorithms":[214],"predicting":[216],"factors":[217],"important":[218],"Furthermore,":[222],"biomarkers":[226],"may":[228],"predict":[229],"can":[237],"be":[238],"better":[239],"understood,":[240],"cellular":[245],"interplay":[246],"between":[247],"malignancy.":[252],"(Abstract)":[253]},"counts_by_year":[],"updated_date":"2026-07-29T14:22:42.915294","created_date":"2025-10-10T00:00:00"}